top of page

Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB


Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...


The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...


Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
Roche will pay a purchase price of USD 2.7B upfront to acquire Carmot Therapeutics
Basel, Switzerland, December 4, 2023 (Globe Newswire) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced its definitive merger...
Merck to Acquire Caraway Therapeutics for $610M
Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and...
Memo Therapeutics AG Appoints Erik van den Berg as CEO
Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier...
Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.
Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its...
Teva names Richard Francis as CEO
Tel Aviv, Israel, November 21, 2023 (Reuters) -- Teva Pharmaceutical (TEVA.TA) has named Richard Francis, former executive at Novartis...
BeiGene finalizes a $1.3B Agreement with Ensem for the CDK2 Inhibitor
Cambridge, MA, November 21, 2023 (MSN) -- BeiGene secures global licensing for Ensem Therapeutics' oral cyclin-dependent kinase-2...
Bristol Myers buys Orum's Blood Cancer Therapy for up to $180M
Princeton, NJ, November 6, 2023 (Reuters) -- Bristol Myers Squibb (BMY.N) acquires an experimental therapy to treat a type of blood...
BioMarin Appoints Alexander Hardy President and CEO
San Rafael, CA, November 1, 2023 (PRNewswire) -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), today announced the appointment of...
Aiolos Bio Launches with $245M Series A
San Francisco & London, October 24, 2023 (Business Wire) -- Aiolos Bio, Inc. has launched as a clinical-stage biopharmaceutical company...
Cordis names Scott Drake as CEO
Miami Lakes, FL, November 6, 2023 (PRNewswire) -- Cordis Board of Directors has named Scott Drake as the new Chief Executive Officer...
Inari Acquires LimFlow, a Limb-Saving Device Manufacturer, in a $415M Deal
Irvine, CA, November 3, 2023 (Finance.yahoo) -- Inari Medical will acquire LimFlow, a company specializing in a device for chronic...
Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines
La Jolla, CA, October 24, 2023 (Business Wire) -- Rampart Bioscience, Inc., a biotechnology firm dedicated to the advancement of...
bottom of page